CONVERGENT VENTURES LLC
CONVERGENT VENTURES LLC is a Pre-seed, Seed and Series A fund in the US writing $500K–$1M checks into AI, Climate, Healthcare, biology, physics, chemistry, data, photonics, biotechnology and diagnostic-equipment.
- Stages
- Pre-seed, Seed, Series A
- Sectors
- AI, Climate, Healthcare, biology, physics, chemistry, data, photonics, biotechnology, diagnostic-equipment
- Check size
- $500K–$1M
- Invests in
- US-wide
- Round role
- Leads rounds
- Actively investing
- Yes
- Founded
- 2021
- Assets under management
- $40M
- Website
- convergentvc.com
Thesis
Convergent Ventures is a venture capital firm founded in 2021 and based in San Francisco, California. The firm invests in early-stage companies, primarily in the United States and North America, that operate at the intersection of fundamental sciences (biology, physics, chemistry) and data/AI. Their focus is on technologies that aim to improve human and planet health, specifically within the healthcare, sustainability, and photonics sectors. Convergent Ventures operates as a seed-stage investor, targeting companies at the pre-seed to Series A stages. They prefer to write the first institutional checks, prioritizing founders and early product development. Their strategy is founder-first, assessing technology, market, and team potential, and they provide strategic guidance, network connections, and operational assistance. The firm has two funds: the "PVP Seed Fund" with $35 million raised in 2021, and a "Venture Capital Fund" with a Gross Asset Value of $40,154,125. They typically invest between $500,000 and $1 million per deal and have made 23 investments to date.
Common questions
Does CONVERGENT VENTURES LLC invest at the Pre-seed stage?
Yes. CONVERGENT VENTURES LLC lists Pre-seed, Seed and Series A among the stages it invests in.
What check size does CONVERGENT VENTURES LLC write?
CONVERGENT VENTURES LLC writes $500K–$1M checks.
Where does CONVERGENT VENTURES LLC invest?
CONVERGENT VENTURES LLC invests in the US.